November 15, 2010 | Filed under: Health,News | Posted by:
People with lupus given the first in a new class of experimental drugs that targets the disease process did better than those given standard treatment, according to one-year results of a large clinical trial.
Posted by
on November 15, 2010. Filed under Health, News.
You can follow any responses to this entry through the RSS 2.0.
You can leave a response or trackback to this entry
Posted by
on November 15, 2010. Filed under